Imaging endpoints in inflammatory bowel disease: current evidence and future directions for ultrasound and MRI.

Date publication

mai 2026

Journal

BMC medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Faggiani I, Danese S, Biroulet LP, Jairath V, Rubin DT, Allocca M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42216172

Résumé

Imaging has become a central and rapidly evolving domain in inflammatory bowel disease (IBD) because it captures disease manifestations that extend beyond the mucosa and, therefore, beyond what can be visualized by endoscopy, including transmural inflammation, extraintestinal complications and small-bowel involvement that are not adequately assessed by conventional approaches.

Mots clés

Crohn’s Disease, Endpoint, Inflammatory Bowel Disease, Intestinal Ultrasound, Magnetic Resonance Imaging, Ulcerative Colitis

Référence

BMC Med. 2026 05 29;: